Medicare Enrolled
Dr. John Defranco, MD
Urology Physician · Chicago Ridge, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Defranco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Defranco?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Defranco
Dr. John Defranco is an urology physician in Chicago Ridge, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Defranco performed 4,904 Medicare services across 2,132 unique beneficiaries.
Between the years covered by Open Payments, Dr. Defranco received a total of $6,047 from 56 pharmaceutical and/or device companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Defranco is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 24% volume in IL
$6,047 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,904
Medicare services
Top 24% in IL for urology physician
2,132
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~245 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 1,300 | $2 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
620 | $90 | $225 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
534 | $8 | $75 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
532 | $3 | $17 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
320 | $0 | $26 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
286 | $34 | $58 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
212 | $49 | $77 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
155 | $2 | $13 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $115 | $361 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
70 | $65 | $149 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
68 | $190 | $822 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
60 | $66 | $210 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
59 | $48 | $377 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
56 | $136 | $409 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
55 | $113 | $488 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
49 | $191 | $892 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
44 | $34 | $58 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
44 | $69 | $117 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
40 | $290 | $1,775 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
36 | $2,377 | $7,596 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
34 | $134 | $565 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
26 | $67 | $560 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
24 | $91 | $228 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
22 | $34 | $58 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
22 | $34 | $58 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
22 | $34 | $58 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
22 | $27 | $136 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
22 | $71 | $247 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
20 | $34 | $58 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
20 | $34 | $58 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
17 | $68 | $600 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
17 | $12 | $74 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
16 | $8 | $13 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,047
Total received (2018-2024)
Avg $864/year across 7 years
Top 28% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,934 (98.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$113 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$950
2023
$766
2022
$896
2021
$883
2020
$883
2019
$972
2018
$697
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$160
Dendreon Pharmaceuticals LLC
$126
ABBVIE INC.
$126
Olympus America Inc.
$119
Bayer Healthcare Pharmaceuticals Inc.
$71
Boston Scientific Corporation
$46
PFIZER INC.
$36
Janssen Biotech, Inc.
$34
Endo USA, Inc.
$33
Laborie Medical Technologies Corp.
$32
Tempus AI, Inc
$29
PROCEPT BioRobotics Corporation
$28
ConvaTec Inc.
$25
ACCORD HEALTHCARE, INC.
$23
COLOPLAST CORP
$22
Tolmar, Inc.
$21
Merck Sharp & Dohme LLC
$17
Top 3 companies account for 43.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$868
Janssen Biotech, Inc.
$645
Dendreon Pharmaceuticals LLC
$430
Sumitomo Pharma America, Inc.
$350
PFIZER INC.
$334
Antares Pharma, Inc.
$275
ABBVIE INC.
$258
Boston Scientific Corporation
$245
Bayer HealthCare Pharmaceuticals Inc.
$174
SRS Medical Systems, Inc.
$143
Endo Pharmaceuticals Inc.
$142
Allergan, Inc.
$130
TOLMAR Pharmaceuticals, Inc.
$129
Olympus America Inc.
$119
Ambu Inc.
$115
Merck Sharp & Dohme LLC
$109
GENZYME CORPORATION
$89
Laborie Medical Technologies Corp.
$77
Travere Therapeutics, Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$71
Retrophin, Inc.
$68
AbbVie Inc.
$67
Myriad Genetic Laboratories, Inc.
$65
AbbVie, Inc.
$62
Teleflex LLC
$62
Foundation Medicine, Inc.
$62
Merck Sharp & Dohme Corporation
$61
Tolmar, Inc.
$55
NeoTract Inc.
$50
Myovant Sciences Inc.
$47
AstraZeneca Pharmaceuticals LP
$43
Coloplast Corp
$42
ConvaTec Inc.
$41
Cardinal Health 414 LLC
$41
IsoRay, Inc
$36
Endo USA, Inc.
$33
Avadel Specialty Pharmaceuticals, LLC
$29
Tempus AI, Inc
$29
DENTSPLY IH Inc.
$29
Amgen Inc.
$28
AngioDynamics, Inc.
$28
PROCEPT BioRobotics Corporation
$28
HealthTronics Mobile Solutions, LLC
$28
Allergan Inc.
$23
ACCORD HEALTHCARE, INC.
$23
COLOPLAST CORP
$22
UROVANT SCIENCES INC
$21
Alnylam Pharmaceuticals Inc.
$20
UROGEN PHARMA, INC.
$19
180 Medical, Inc.
$19
BOSTON SCIENTIFIC CORPORATION
$18
Aytu BioScience, Inc
$16
Accord Healthcare, Inc.
$16
Cook Incorporated
$15
Metuchen Pharmaceuticals
$13
Clarus Therapeutics Inc.
$6
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · BOTOX · BOTOX THERAPEUTIC · Brachytherapy Source · CAMCEVI · COOK MEDICAL DILATION/ACCESS · ELIGARD · EMBLEM MRI S-ICD · ERLEADA · EndoSheath Technology · Erleada · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL - BPH · GENTLECATH · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron Depot · MYRBETRIQ · Mobile Laser Services · NOCDURNA · NanoKnife · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PROVENGE · Porges Coloplast · Prolaris · Prolia · REZUM · SPACEOAR · SPEEDICATH · SUTENT · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · TOVIAZ · Thiola · Tria Firm · UROLIFT · UroCuff · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
321
Per 100K population
6.2
County median income
$81,797
Nearest hospital
ADVOCATE CHRIST HOSPITAL & MEDICAL CENTER
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Defranco is a clinical cardiology specialist, with above-average Medicare volume (top 24% in IL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Defranco experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Defranco performed 1,300 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Defranco receive payments from pharmaceutical companies?
Yes. Dr. Defranco received a total of $6,047 from 56 companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Defranco's costs compare to other urology physicians in Chicago Ridge?
Dr. Defranco's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Defranco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Chicago Ridge
Browse urology physicians in Chicago Ridge ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology